15-26779189-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000541819.6(GABRB3):​c.249-6417A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.89 in 152,114 control chromosomes in the GnomAD database, including 60,706 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.89 ( 60706 hom., cov: 32)

Consequence

GABRB3
ENST00000541819.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.463

Publications

7 publications found
Variant links:
Genes affected
GABRB3 (HGNC:4083): (gamma-aminobutyric acid type A receptor subunit beta3) This gene encodes a member of the ligand-gated ionic channel family. The encoded protein is one the subunits of a multi-subunit chloride channel that serves as the receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter of the mammalian nervous system. This gene is located on the long arm of chromosome 15 in a cluster with two other genes encoding related subunits of the family. This gene may be associated with the pathogenesis of several disorders including Angelman syndrome, Prader-Willi syndrome, nonsyndromic orofacial clefts, epilepsy and autism. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2013]
GABRB3 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 43
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • epilepsy, childhood absence, susceptibility to, 5
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000541819.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000541819.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRB3
ENST00000541819.6
TSL:1
c.249-6417A>G
intron
N/AENSP00000442408.2F5H7N0
GABRB3
ENST00000557641.5
TSL:5
n.453-6417A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.890
AC:
135308
AN:
151996
Hom.:
60667
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.767
Gnomad AMI
AF:
0.810
Gnomad AMR
AF:
0.927
Gnomad ASJ
AF:
0.951
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.983
Gnomad FIN
AF:
0.943
Gnomad MID
AF:
0.877
Gnomad NFE
AF:
0.932
Gnomad OTH
AF:
0.898
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.890
AC:
135405
AN:
152114
Hom.:
60706
Cov.:
32
AF XY:
0.894
AC XY:
66469
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.767
AC:
31787
AN:
41460
American (AMR)
AF:
0.927
AC:
14175
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.951
AC:
3299
AN:
3470
East Asian (EAS)
AF:
0.998
AC:
5129
AN:
5138
South Asian (SAS)
AF:
0.983
AC:
4741
AN:
4822
European-Finnish (FIN)
AF:
0.943
AC:
9997
AN:
10602
Middle Eastern (MID)
AF:
0.871
AC:
256
AN:
294
European-Non Finnish (NFE)
AF:
0.932
AC:
63387
AN:
68024
Other (OTH)
AF:
0.899
AC:
1897
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
740
1480
2219
2959
3699
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.897
Hom.:
8964
Bravo
AF:
0.882
Asia WGS
AF:
0.973
AC:
3382
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.6
DANN
Benign
0.37
PhyloP100
-0.46
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7165224;
hg19: chr15-27024336;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.